According to the CDC, more than one-third of the world's population lives in areas at risk for and infection the virus is a leading cause of illness and death in the tropics and subtropics. The BioFront Technologies line of anti-Dengue virus monoclonal antibodies produce reliable and trusted results for researchers leading the fight against this global issue.